awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36166836-739A7E42-9BCB-4995-9DC5-A206B38FE240
Q36166836-739A7E42-9BCB-4995-9DC5-A206B38FE240
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36166836-739A7E42-9BCB-4995-9DC5-A206B38FE240
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer
P2860
Q36166836-739A7E42-9BCB-4995-9DC5-A206B38FE240
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36166836-739A7E42-9BCB-4995-9DC5-A206B38FE240
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
64cc925e587ac3338bd5961f8e01acbf53c473cf
P2860
Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma.